bicalutamide

This medicine is used to inhibit the growth of prostate cancer and to improve quality of life. It is prescribed to men with inoperable metastatic prostate cancer or for the treatment of non-metastatic prostate cancer in combination with radiotherapy or surgery.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: ACCORD HEALTHCARE, S.L.U.

This medicine is used for the treatment of prostate cancer. It works by blocking the effect of male hormones, such as testosterone.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: Eugia Pharma (Malta) Limited

This medicine is used for the treatment of prostate cancer. It may be prescribed alone or in combination with other treatments, such as radiotherapy, surgical castration, or drugs that reduce androgen levels.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: Eugia Pharma (Malta) Limited

It is used for the treatment of advanced prostate cancer or locally advanced prostate cancer with a high risk of progression. It can be taken alone or in combination with other treatments such as radiotherapy, surgical removal of the testes, or an LHRH analogue drug.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: DOC GENERICI SRL

It is used to treat prostate cancer by acting to block the effects of male hormones, such as testosterone.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: IBIGEN S.R.L.

It is used for the treatment of advanced prostate cancer (in combination with other treatments or after surgical removal of the testes) and for the treatment of non-metastatic prostate cancer in adult men, when castration or other therapies are not indicated or acceptable.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: RATIOPHARM GMBH

It is used for the treatment of advanced prostate cancer. It can be used alone, in combination with other treatments for patients who have had their prostate removed, or in association with radiotherapy when the cancer has spread from the gland to nearby tissue.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.

It is used for the treatment of prostate cancer and works by blocking the effect of male hormones, such as testosterone.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: TECNIMEDE - SOCIEDADE TECNICO-MEDICINAL, SA

It is used in adult males for the treatment of prostate cancer (in combination with other therapeutic methods to reduce male sex hormones) or for non-metastatic prostate cancer in cases where castration or other types of therapy are not indicated or are unacceptable.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: TEVA ITALIA S.R.L.

It is used in adult men for the treatment of prostate cancer. The 50 mg version is used in combination with other drugs (LHRH analogues) or after surgical castration, while the 150 mg version is used for non-metastatic prostate cancer when castration or other treatments are not indicated or acceptable.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: ECUPHARMA S.R.L.

It is used for the treatment of prostate cancer. It works by reducing the amount of testosterone produced by the body and can be prescribed alone or in combination with other medicines, for example after prostate removal or after a course of radiotherapy.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: LABORATOIRES JUVISE PHARMACEUTICALS

Midelut is indicated for the treatment of prostate cancer and works by blocking the effects of male hormones such as testosterone.

Form: tablets, film-coated

ATC: L02BB03

Manufacturer: SOPHOS BIOTECH S.R.L.